back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-28 17:20 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
46 - Compensation for services
|
$55,000
+846,154 vol $0.065 each |
846,154 | |
| Filed 2023-12-28 17:10 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-10 15:37 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-490,000
-700,000 vol $0.70 each |
0 | |
| Filed 2021-05-27 17:51 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,245
+18,000 vol $0.0692 each |
363,000 | |
| Filed 2021-05-27 17:30 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$19,718
+237,000 vol $0.0832 each |
700,000 | |
| Filed 2021-05-27 17:29 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
463,000 | |
| Filed 2021-05-27 17:28 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
||
| Filed 2021-05-27 17:27 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,700
+50,000 vol $0.074 each |
413,000 | |
| Filed 2021-05-27 17:24 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,245
+18,000 vol $0.0692 each |
||
| Filed 2021-05-27 17:20 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,919
+200,000 vol $0.53 each |
1,000,000 | |
| Filed 2021-05-27 17:18 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,500
+100,000 vol $0.485 each |
800,000 | |
| Filed 2021-05-27 17:17 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,500
+90,000 vol $0.45 each |
700,000 | |
| Filed 2021-05-27 17:16 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,250
+90,000 vol $0.425 each |
610,000 | |
| Filed 2021-05-27 17:15 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,875
+175,000 vol $0.405 each |
520,000 | |
| Filed 2021-05-27 17:14 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,332
+18,000 vol $0.074 each |
||
| Filed 2021-05-27 17:12 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,332
+18,000 vol $0.074 each |
||
| Filed 2021-05-27 17:09 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,919
+200,000 vol $0.53 each |
||
| Filed 2021-05-27 17:08 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,500
+100,000 vol $0.485 each |
||
| Filed 2021-05-27 17:07 Tx date 2021-05-21 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,500
+90,000 vol $0.45 each |
||
| Filed 2021-05-27 17:07 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,250
+90,000 vol $0.425 each |
||
| Filed 2021-05-27 17:05 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,875
+175,000 vol $0.405 each |
||
| Filed 2021-03-08 15:03 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$241,499
+345,000 vol $0.70 each |
345,000 | |
| Filed 2021-03-08 15:02 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-08 15:02 Tx date 2021-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,100
+345,000 vol $0.58 each |
345,000 | |
| Filed 2021-03-08 15:01 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-21 12:42 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 |